TrialThe Journal of clinical investigation2018

Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.

Maureen P Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.